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Oncostatin M and cAMP signaling stimulate apical surface-directed membrane trafficking and apical lumen development
in hepatocytes, both in a protein kinase A (PKA)-dependent manner. Here, we show that oncostatin M, but not cAMP,
promotes the A-kinase anchoring protein (AKAP)-dependent anchoring of the PKA regulatory subunit (R)II to subapical
centrosomes and that this requires extracellular signal-regulated kinase 2 activation. Stable expression of the RII-
displacing peptide AKAP-IS, but not a scrambled peptide, inhibits the association of RII with centrosomal AKAPs and
results in the repositioning of the centrosome from a subapical to a perinuclear location. Concomitantly, common
endosomes, but not apical recycling endosomes, are repositioned from a subapical to a perinuclear location, without
significant effects on constitutive or oncostatin M-stimulated basolateral-to-apical transcytosis. Importantly, however, the
expression of the AKAP-IS peptide completely blocks oncostatin M-, but not cAMP-stimulated apical lumen develop-
ment. Together, the data suggest that centrosomal anchoring of RII and the interrelated subapical positioning of these
centrosomes is required for oncostatin M-, but not cAMP-mediated, bile canalicular lumen development in a manner that
is uncoupled from oncostatin M-stimulated apical lumen-directed membrane trafficking. The results also imply that
multiple PKA-mediated signaling pathways control apical lumen development and that subapical centrosome positioning
is important in some of these pathways.
INTRODUCTION
Polarized hepatocytes, like all epithelial cells, display dis-
tinct plasma membrane domains, an apical plasma mem-
brane domain facing the bile canalicular lumen, and a baso-
lateral plasma membrane domain facing the space of Disse.
Concomitant with cell surface polarity, also the cell interior
displays a polarized organization. A dense cortical actin
network is assembled beneath the apical surface and actin
filaments extend into apical microvilli with their barbed
ends facing the microvilli tips. In addition, part of the mi-
crotubule cytoskeleton is oriented parallel to the apical–
basolateral axis with their minus and plus ends facing the
apical and basolateral surface, respectively. The cytoskele-
ton organization influences the position of the centrosome
(Burakov et al., 2003), which in various epithelial cells in-
cluding intestinal Caco-2, kidney Madin-Darby canine kid-
ney (MDCK), and hepatic WIF-B cells, is typically oriented
toward the apical surface (Buendia et al., 1990; Meads and
Schroer, 1995; Salas, 1999). Polarized positioning of the cen-
trosome is thought to play a role in the establishment of
epithelial cell polarity (Zeligs, 1979; Dylewski and Keenan,
1984; Houliston et al., 1987; Rizzolo and Joshi, 1993) and
neuronal polarity (de Anda et al., 2005; Higginbotham et al.,
2006). A subapical position of the centrosome may be im-
portant for the polarized orientation of microtubule-associ-
ated organelles such as the Golgi apparatus and recycling
endosomes, and, in this way, facilitate the polarized, at least
apical, trafficking of proteins and lipids from these intracel-
lular organelles to the appropriate surface domain (Wald et
al., 2003; Musch, 2004). However, kidney epithelial MD-
CKII-J cells, which display a persistent perinuclear centro-
some position and microtubule organization, do not show
defects in polarity development or protein delivery from the
Golgi apparatus to the different membrane domains, argu-
ing for a nonessential role for centrosome position and mi-
crotubule organization in cell polarity development (Grind-
staff et al., 1998). In the Caenorhabditis elegans oocyte,
however, the centrosome is critical to initiate cell polarity
but independent of its role as a microtubule nucleator. Here,
the centrosome was proposed to provide a specific but un-
identified polarity signal (Cowan and Hyman, 2004), which
is in agreement with the emerging view of the centrosome as
a signaling unit (for review, see Diviani and Scott, 2001;
Lange, 2002). Whether the centrosome and its subcellular
positioning play a general role in the development of (epi-
thelial) cell polarity thus remains uncertain.
Hepatocyte polarity development is regulated by kinases,
often in response to extracellular signals. For example, acti-
vation of the serine/threonine protein kinase C (PKC) in
well-differentiated human hepatoma HepG2 cells or in iso-
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lated rat hepatocyte couplets with phorbol esters or vaso-
pressin, respectively, perturbs hepatocyte polarity and re-
sults in a loss of bile canalicular lumens and a redistribution
of bile canalicular markers (Zegers and Hoekstra, 1997;
Roma et al., 1998; Kubitz et al., 2001). By contrast, the mam-
malian orthologue of Caenorhabditis elegans Par-1 (EMK1;
MARK2), which controls microtubule dynamics, is required
for the development of apical bile canalicular lumens in rat
hepatic WIF-B9 cells (Cohen et al., 2004). Phosphoinositide
3-kinase and the p38 mitogen-activated protein (MAP) ki-
nase control tauro(ursodeoxy)cholate-induced trafficking of
ATP-dependent transporters to the canalicular surface in rat
liver, isolated hepatocytes, and hepatic cell lines (Misra et al.,
1998; Sai et al., 1999; Kubitz et al., 2004), whereas Vps34p, a
class III phosphoinositide 3-kinase, prevents the internaliza-
tion of canalicular proteins from the canalicular surface
(Tuma et al., 2001), in this way contributing to the functional
composition of the apical lumen surface. Activation of
cAMP-dependent serine/threonine protein kinase A (PKA)
in WIF-B(9) cells, isolated hepatocyte couplets, or HepG2
cells with 1) forskolin, a compound produced by Coleus
forskohlii that activates adenylyl cyclase to increase the intra-
cellular levels of cAMP; 2) glucagon, a pancreatic hormone
that similarly activates hepatic adenylyl cyclase to raise
cAMP concentrations; 3) the cAMP phosphodiesterase in-
hibitor 3-isobutyl-1-methylxanthine, or 4) cell-permeable
stable cAMP analogues generally stimulates the polarized
delivery of apical bile canalicular proteins and lipids and the
concomitant development of apical bile canalicular lumens
(Zegers and Hoekstra, 1997; van IJzendoorn and Hoekstra,
1999; Roma et al., 2000; Kagawa et al., 2002; Gradilone et al.,
2003). In addition, PKA protects hepatocytes against radical
oxygen species-induced tight junction impairment (Perez et
al., 2006), thus preserving separate apical and basolateral
environments. Also, when freshly cultured HepG2 cells are
exposed to the PKA inhibitor H89, further cell polarity de-
velopment is prevented (van IJzendoorn and Hoekstra,
2000). The fundamental role of PKA in hepatocyte polarity
development is underscored by the observation that baso-
laterally circulating oncostatin M (OSM), an interleukin-6
family cytokine involved in fetal liver maturation (Kamiya et
al., 2001), stimulates membrane traffic toward the bile cana-
licular plasma membrane and bile canalicular lumen devel-
opment in a PKA-dependent manner (van der Wouden et al.,
2002).
How oncostatin M- and cAMP/PKA-mediated signaling
routes intermingle is not known. Clearly, a coordinated
spatial regulation of signaling within the cellular space is
pivotal for a basolaterally localized stimulus to promote the
development of an apical lumen, which are about ten mi-
crons apart. This is, for example, illustrated by the recruit-
ment of the signal transducing receptor subunit gp130 into
lipid rafts at the basolateral surface of HepG2 cells in re-
sponse to oncostatin M (van der Wouden et al., 2002). As for
PKA, there are two isoforms, PKA type I and type II, both of
which are holoenzymes consisting of two regulatory (RI/
or RII/, respectively) and two catalytic subunits (C). The
autoinhibitory interaction between R and C is relieved when
cAMP, produced by adenylyl cyclase, binds to the regula-
tory subunits, triggering their dissociation from the catalytic
subunits and subsequent phosphorylation of target proteins
by C. In HepG2 and other cells, most PKA type II is an-
chored at specific organelles and cellular structures through
A-kinase anchoring proteins (AKAPs), which, in conjunction
with (phosphodiesterase-)regulated spatial cAMP gradients
and other proteins tethered to AKAPs, provide an important
level of control to ensure specificity of cAMP/PKA-medi-
ated signal transduction (Michel and Scott, 2002). It has been
shown that exposure of HepG2 cells to oncostatin M does
not result in a detectable increase in cAMP levels or a
pronounced increase in overall PKA activation, which is in
striking contrast to treatment of the cells with forskolin or
cAMP analogues. Intriguingly, however, it was noticed that
oncostatin M signaling stimulated the association of the
regulatory subunit of type II PKA (PKA-RII) with the cen-
trosomal region (van der Wouden et al., 2002). In this study,
we have examined the role of PKA-RII anchoring at cen-
trosomes in hepatocyte polarity development.
MATERIALS AND METHODS
Cell Culture
Human hepatoma HepG2 cells (American Type Culture Collection, Manas-
sas, VA) were grown in DMEM supplemented with l-glutamine, 10% fetal
calf serum (FCS), and penicillin/streptavidin, as described previously (Zegers
et al., 1997). HepG2 cells stably expressing the GFP/V5/His-tagged AKAP-IS
peptide or scrambled peptide (GFP-QDVEIQLKAAYNQKLIAI-V5/His) (pro-
vided by John Scott (Howard Hughes Medical Institute, Vollum Institute,
Oregon Health & Science University, Portland, OR 97239) and described in
Alto et al. (2003)) were created as described previously (Wojtal et al., 2006).
Stable transfectants were cultured in medium supplemented with 800 g/ml
Geneticin (G-418; Invitrogen, Carlsbad, CA). For immunofluorescence exper-
iments, cells were plated onto ethanol-sterilized uncoated glass coverslips.
Determination of Cell Proliferation
Parental HepG2 and AKAP-IS–expressing HepG2 cells were plated at a
concentration of 500,000 cells per coverslip (20  20 mm) and counted every
24 h using a Bu¨rker chamber. The average of two different countings is
depicted.
Flow Cytometry
Cells were washed with phosphate-buffered saline (PBS) and with PBS/0.1%
EDTA, and incubated in PBS/0.1% EDTA at 37°C during 5 min. The cells
were resuspended to obtain a single cell solution and centrifuged at 1000 rpm
for 5 min. After washing with PBS/1% FCS, the cell pellet was resuspended
in 100 l of PBS. One milliliter of 20°C absolute ethanol was added using a
vortex to avoid clumping, and cells were kept in ethanol at 4°C for 15 min and
centrifuged at 1600 rpm for 5 min. After washing with PBS/FCS, the cells
were suspended in a propidium iodide solution (10 g/ml propidium iodide
in 38 mM sodium citrate, pH 7. 4, 250 g/ml RNase A in PBS/1% FCS) and
incubated at 37°C for 30 min. The cells were stored in the fridge and protected
from light until analysis with a FACSCalibur flow cytometry apparatus, using
CellQuest software for the data acquisition and Modfit for the data analysis
(BD Biosciences, San Jose, CA).
Determination of Cell Polarity
The evaluation of polarity was performed as described previously (Zegers et
al., 1997; van IJzendoorn et al., 2000). Briefly, cells were plated onto coverslips,
and after 72 h they were fixed with absolute ethanol (20°C) for 10 s, washed
with PBS, and subsequently incubated with a mixture of tetramethylrhodam-
ine isothiocyanate (TRITC)-labeled phalloidin (100 ng/ml) and Hoechst-33528
(5 ng/ml) at room temperature (RT) for 30 min. The coverslips were then
washed with PBS and mounted. The level of polarity was determined by
counting of the number of TRITC–phalloidin-positive bile canaliculi (BC) per
100 cells, and level is expressed in percentage. At least 10 fields each contain-
ing 300 cells were counted using an epifluorescence microscope (Provis
AX70; Olympus, New Hyde Park, NY).
Immunofluorescence Labeling of Cells
For centrosomal staining, cells were treated with cold Hanks’ balanced salt
solution (HBSS) containing Triton X-100 (1%, vol/vol) for 2 min at 4°C and
immediately fixed with 20°C absolute methanol for 10 min at 20°C. Cells
were then washed with PBS and blocked with bovine serum albumin (BSA)
(1%, wt/vol) in HBSS for 1 h at RT. Cells were incubated with mouse
monoclonal anti-PKA-RII (BD Biosciences Transduction Laboratories, Lex-
ington, KY), rabbit polyclonal anti--tubulin (Sigma-Aldrich, St. Louis, MO),
and/or rabbit anti-pericentrin (Covance, Princeton, NJ) primary antibodies
for 2 h at RT or alternatively overnight at 4°C. For staining of microtubules
and apical recycling endosomes (AREs), cells were fixed with paraformalde-
hyde (4%, wt/vol) and permeabilized with Triton X-100 (0.1%, vol/vol) and
subsequently incubated with mouse anti--tubulin (Sigma-Aldrich) or rabbit
anti-rab11a (Zymed Laboratories, South San Francisco, CA) antibodies, re-
spectively. The cells were then washed and incubated with the corresponding
secondary antibodies labeled with either Alexa Fluor-488 or -594 (Invitrogen)
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for 1 h at RT and 5 ng/ml Hoechst to stain the nuclei or TRITC-phalloidin
(Sigma-Aldrich) to stain apical actin cytoskeleton to visualize BCs. The cov-
erslips were mounted and analyzed by epifluorescence microscopy (Provis
AX70; Olympus).
Quantification of PKA-RII–positive Centrosomes
The percentage of PKA-RII–positive centrosomes was determined by count-
ing the number of -tubulin–stained centrosomes that were positive or neg-
ative for PKA-RII. The number of PKA-RII–positive centrosomes was
expressed as the percentage of total number of centrosomes. Several fields of
several coverslips were analyzed.
Cell Lysis, Protein Determination, and Trichloroacetic
Acid (TCA) Precipitation
Cells were scraped in ice-cold NP-40 lysis buffer, pH 7.4, supplemented with
a cocktail of protease inhibitors. An homogenous lysate was obtained by
resuspending the cells through the 24-gauge needle. Ten microliters of lysate
was processed for protein determination using bicinchoninic acid and CuSO4
method. Equal amounts of proteins were precipitated by TCA. Briefly, sam-
ples containing equal amount of proteins were complemented until a total
volume of 1 ml with fractionation buffer (supplemented with a cocktail of
protease inhibitors) was reached. Afterward, 5 l of 25 mg/ml deoxycholic
acid was added to each sample and incubated on ice for 5 min. Proteins were
then precipitated by adding 60 l of 100% TCA followed by 15-min incuba-
tion on ice. Proteins were pelleted at 10,000  rpm at 4°C for 20 min, after
which the pellet was dried under vacuum, resuspended in sample buffer
containing SDS (2%, wt/vol), 1% -mercaptoethanol, 10% glycerol, 50 mM
Tris, pH 6.8, and 0.02% bromophenol blue (BFB), and boiled for 4 min.
SDS-Polyacrylamide Gel Electrophoresis (PAGE) and
Western Blotting
Protein samples were separated with SDS-PAGE 10% acrylamide and subse-
quently transferred to polyvinylidene difluoride (PVDF) or nitrocellulose
membranes. Membranes were blocked with 5% nonfat dry milk in PBS-Tween
20 (0.3%, vol/vol) and incubated with monoclonal anti-PKA RII (BD Bio-
sciences Transduction Laboratories), monoclonal mouse anti- -actin (Sigma-
Aldrich), or goat polyclonal anti-PKA-RII (Upstate Biotechnology, Lake
Placid, NY) antibodies at room temperature for 2 h. For total expression of
PKA-RII and AKAP350, membranes were incubated with mouse monoclo-
nal anti-PKA-RII antibody (BD Biosciences Transduction Laboratories) or
mouse anti-AKAP350 antibody (gift from Dr. Goldenring, Vanderbilt Univer-
sity, School of Medicine, Nashville, TN 37232) for 2 h at RT in PBS containing
0.1% Tween. For phosphorylation of extracellular signal-regulated kinase
(ERK)1/2, cells were lysed as described above, and 30 g of total protein was
suspended in sample buffer containing 2% SDS, 1% -mercaptoethanol, 10%
glycerol, 50 mM Tris, pH 6.8, and 0.02% BFB, boiled for 4 min, and processed
for SDS-PAGE and transferred onto nitrocellulose or PVDF membranes. After
transfer, membranes were blocked with 5% nonfat dry milk in Tris-buffered
saline (TBS) (1%, vol/vol Tween) and incubated overnight at 4°C with
rabbit anti-p44/p42 MAP kinase or mouse anti-phospho-p44/p42 MAP ki-
nase antibodies (Cell Signaling Technology, Danvers, MA), or mouse anti-
p27Kip1 (BD Biosciences, Transduction Laboratories) antibodies in TBS con-
taining 5% (wt/vol) BSA. Membranes were then washed three times for 5 min
with PBS-Tween 20 (0.3%, vol/vol) and incubated with corresponding sec-
ondary horseradish peroxidase-conjugated antibodies (GE Healthcare, Little
Chalfont, Buckinghamshire, United Kingdom) at room temperature for 1 h
and processed for enhanced chemiluminescence detection (GE Healthcare).
Bands were quantified using free Scion Imaging software (Scion, Frederick,
MD; www.scioncorp.com).
Quantification of Expression of Pericentrin
HepG2 cells were plated onto glass coverslips, and after 72 h, they were
subjected to treatment with 10 ng/ml OSM or 1 mM dibutyryl (db)-cAMP for
4 h. Cells were then fixed with cold methanol at 20°C for 10 min. After
blocking with 1% of BSA in PBS for 1 h at RT, coverslips were incubated with
primary rabbit anti-pericentrin antibody (Covance) overnight at 4°C. After
washing three times with PBS, coverslips were probed with corresponding
anti-rabbit Alexa-594 (Invitrogen) at RT for 1 h. Coverslips were mounted and
processed for fluorescence microscopy (Provis AX70; Olympus) by using 60
objective. Several images were taken from different fields of each coverslip
using analySIS (Soft Imaging Systems, Mu¨nster, Germany) at 1-s exposure
time, and all other used software settings were standardized for accurate
comparison between images. The intensity of fluorescence was measured by
free Scion Imaging software.
Synthesis of C6-Nitro-benzoxa-diazole
(C6-NBD)-Sphingomyelin
C6-NBD-sphingomyelin (SM) was synthesized from C6-NBD and sphingo-
sylphosphorylcholine as described previously (van der Wouden et al., 2002).
The C6-NBD-SM was stored at 20°C and routinely checked for purity.
Transcytosis of Sphingolipids
HepG2 cells expressing the AKAP-IS peptide or not were washed three times
in HBSS and preincubated for 30 min at 37°C in HBSS supplemented or not
with 10 ng/ml OSM. After the preincubation, the cells were cooled to 4°C by
washing with ice-cold HBSS. Subsequently, the basolateral plasma membrane
(PM) was labeled with 4 M C6-NBD-SM for 30 min at 4°C in HBSS supple-
mented or not with OSM, which allows incorporation of the lipid probe in the
exoplasmic leaflet of the basolateral plasma membrane while preventing its
internalization (van IJzendoorn et al., 1997). When cells had been pretreated
with OSM, the cytokine was included in all further incubations. After incor-
poration of the lipid probe in the basolateral plasma membrane, cells were
washed, and transcytosis was allowed to occur at 37°C for different time periods.
To terminate transport, the cells were cooled by washing three times with
ice-cold HBSS, and lipid remaining in the outer leaflet of the basolateral mem-
brane was removed by a back-exchange procedure. To this end, the cells were
incubated for 30 min at 4°C with 5% BSA in HBSS, followed by washing with
ice-cold HBSS. This procedure was repeated once (van IJzendoorn et al., 1997).
Labeling of the CE/SAC with Fluorescent Lipid Analogues
The CE/SAC was labeled with the lipid analogue exactly as described in
detail previously (van IJzendoorn and Hoekstra, 1998, 1999). In brief, cells
were labeled with 4 M C6-NBD-SM at 37°C to allow internalization from the
basolateral surface and subsequent transcytosis to the apical, BC PM domain.
After 30 min of incubation, lipid analogue still residing at the basolateral
domain was depleted by a back-exchange procedure at 4°C (2  30-min
incubation in HBSS  5%, wt/vol BSA; compare with van IJzendoorn et al.,
1997), and BC-associated lipid analogue was chased into the SAC at 18°C for
1 h in back-exchange medium. Then, the NBD fluorescence at the exoplasmic
leaflet of the bile canalicular plasma membrane was destroyed using sodium
dithionite at 4°C, leaving the majority of the lipid probe-derived fluorescence
in the SAC (van IJzendoorn and Hoekstra, 1998, 2000).
RESULTS
OSM but Not Dibutyryl-cAMP Stimulates the
Association of PKA-RII with Centrosomes
In a previous study, we observed that OSM-stimulated and
PKA-dependent apical lumen development in HepG2 cells
coincided with an increased localization of PKA-RII at the
centrosomal region (van der Wouden et al., 2002). To inves-
tigate this in more detail, cells were treated with 10 ng/ml
human recombinant OSM or buffer (control) in the extracel-
lular medium at 37°C for 4 h, fixed, and immunolabeled
with mouse monoclonal antibodies against PKA-RII and
rabbit polyclonal antibodies against the centrosomal protein
-tubulin. In untreated HepG2 cells in interphase, typically
one -tubulin–positive centrosome consisting of two centri-
oles was observed per cell (Figure 1A). In polarized cells, on
average 2.3  0.2 centrosomes, identified by -tubulin stain-
ing, were counted within a 2-m distance from each apical
surface (BC; Figure 2A), consistent with the participation of
typically two to three cells per apical lumen (cf. Herrema et
al., 2006). Most centrosomes are therefore subapically posi-
tioned in polarized cells (Figure 1, A–C, merged image in D).
There were no differences in -tubulin staining between
nontreated and OSM-treated cells (cf. Figure 1, A–D), and
identical results were obtained with antibodies against peri-
centrin (data not shown).
Immunofluorescence microscopy revealed the presence of
PKA-RII in the cytosol, in the nucleus, and at the centrosome
(Figure 1, A and B). Centrosomal PKA-RII seemed to local-
ize at the pericentriolar material surrounding and partially
overlapping with the individual pericentrin-positive centrioles
(Figure 1, E–G), which is in accordance with the localization of
PKA anchoring proteins such as AKAP350 and pericentrin at
the pericentriolar material (Keryer et al., 1993; Doxsey et al.,
1994). The percentage of PKA-RII–containing centrosomes
was determined by counting centrosomes, identified by -tu-
bulin staining, that were positive for PKA-RII. In untreated
cells, PKA-RII was detected at 48% of the (-tubulin–posi-
tive) centrosomes (Figure 2B). The majority of the centrosomes
that seemed devoid of PKA-RII was found in interphase cells
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(evidenced by DNA staining), and a minor fraction (4%) was
found in mitotic cells, the latter of which never showed PKA-
RII at the centrosome (our unpublished data). The percentage
of -tubulin–positive centrosomes that harbored PKA-RII in-
creased to 65% in OSM-treated cells (p  0.01; Student’s t
test) (Figure 2B). Determination of the percentage of centro-
somes containing PKA-RII that are within a 2-m distance
from an apical lumen showed an increase from an average of
1.0–1.4 per lumen (p  0.05) in nontreated and OSM-treated
cells, respectively (Figure 2C), whereas the percentage of total
centrosomes (i.e., irrespective of PKA-RII association) within
a 2-m distance of an apical lumen remained constant at an
average of2.3 per lumen (Figure 2A). These data suggest that
OSM stimulates the association of PKA-RII with already sub-
apical centrosomes.
Both OSM and PKA positivity of centrosomes have been
correlated to cell entry in or exit out of the G1 phase of the
cell cycle. We therefore examined the expression level of
p27Kip1 (a cyclin-dependent kinase inhibitor that controls
G1 progression, which typically changes as a function of cell
cycle progression). However, during the relatively short
time interval of incubation with OSM, no changes in the
expression level of p27Kip1 were observed (Supplemental
Figure S1A). The stimulatory effect of OSM on the associa-
tion of PKA-RII with centrosomes therefore is unlikely the
result of changes in cell cycle.
OSM-elicited signaling cascades involve, among others,
the p42 MAP kinase/ERK2, which becomes phosphorylated
upon treatment of the cells with OSM (Figure 2D), in agree-
ment with previous reports (Klausen et al., 2000). Treatment
of the cells with PD98059, a compound that binds to the
ERK-specific MAP kinase kinase (MEK) and in this way
prevents phosphorylation of ERK by MEK, prevented the
OSM-stimulated phosphorylation of ERK2 (Figure 2D) and
inhibited the OSM-stimulated association of PKA-RII with
centrosomes (Figure 2B). This suggests that the enhanced
association of PKA-RII with centrosomes in response to
OSM requires the OSM-mediated activation of ERK2 via
MEK.
In contrast to OSM, treatment of HepG2 cells with the
membrane-permeable and stable cAMP analogue db-cAMP
at 1 mM, which effectively stimulates PKA activity in HepG2
(van der Wouden et al., 2002) and other cells, did not stim-
ulate the association of PKA-RII with centrosomes (Figure
2B). Note that the cellular expression level of PKA-RII and
two known centrosomal AKAPs, pericentrin and AKAP350
(a.k.a. AKAP450 or CG-NAP), did not change upon treat-
ment of the cells with OSM or db-cAMP, as evidenced by
Western blot (RII and AKAP350; Figure 2E) or quantitative
immunofluorescence (pericentrin, Figure 2F), suggesting
that the OSM-enhanced association of PKA-RII with cen-
trosomes reflected a redistribution of the protein rather than
an increase in expression.
To determine whether the catalytic activity of PKA was
required for the OSM-stimulated association of PKA-RII
with centrosomes, cells were treated with OSM in combina-
tion with the ATP-site PKA inhibitors H89 or KT5720. These
structurally different inhibitors were shown in our labora-
tory to effectively inhibit cAMP-stimulated development of
apical lumens in HepG2 cells (Zegers and Hoekstra, 1997;
van IJzendoorn and Hoekstra, 1999, 2000; Supplemental Fig-
ure S2). As shown in Figure 2B, H89 and KT5720 did not
interfere with the OSM-stimulated association of PKA-RII
with centrosomes, suggesting that catalytic activity of PKA
is not required.
Together, the data show that in HepG2 cells, robust PKA-
RII staining is detected at 48% of (-tubulin–positive) cen-
trosomes and that treatment of the cells with OSM, but not
db-cAMP, causes a significant MEK–ERK2-dependent in-
crease in the association of PKA-RII at centrosomes.
Inhibition of PKA-RII Anchoring at Centrosomes
Interferes with the Subcellular Positioning of the
Centrosome and Common Endosome
To confirm that the OSM-stimulated association of PKA-
RII with centrosomes occurs via an AKAP, and to investi-
gate whether the OSM-stimulated association of PKA-RII
with centrosomes plays a role in OSM-stimulated bile can-
alicular lumen development (van der Wouden et al., 2002;
van IJzendoorn et al., 2004a), HepG2 cells were stably trans-
fected with epitope-tagged AKAP-IS, a peptide that specif-
ically binds to PKA-RII with high affinity and displaces it
from its natural anchoring sites, or, as a control, stably
transfected with an epitope-tagged nonfunctional scrambled
peptide (details with regard to these peptides are described
Figure 1. Localization of centrosomes in polarized HepG2 cells.
Seventy-two hours after plating, HepG2 cells were stained with
anti--tubulin antibody to visualize centrosomes (A) and TRITC-
phalloidin to stain apical surfaces (B). In polarized cells, most cen-
trosomes (arrows) localize at the apical surface (D), some of which
are positive for PKA-RII as shown in the bottom panel (A, B, and
D). Nuclei were stained with Hoechst (C and C). (E–G) A close-up
shows that PKA-RII (F) is localized at the pericentriolar mesh,
surrounding and partially overlapping with the pericentrin-positive
centrioles (E). Merged image in G. Bars, 20 m (A–D) and 0.5 m
(E–G).
K. A. Wojtal et al.
Molecular Biology of the Cell2748
in Alto et al., 2003). Stable transfectants were selected, and
they were shown to express AKAP-IS or the scrambled
peptide and displace PKA-RII from natural anchoring sites
or not, respectively (cf. Wojtal et al., 2006). In cells stably
expressing the AKAP-IS peptide, but not the scrambled
peptide, the percentage of PKA-RII–positive centrosomes
(identified by -tubulin) was significantly reduced (Figure
3A). The expression level of PKA-RII in cells expressing the
peptide was not changed compared with parental HepG2
cells (cf. Wojtal et al., 2006). Importantly, in contrast to
parental HepG2 cells or HepG2 cells expressing the scram-
bled peptide, treatment of cells expressing the AKAP-IS
peptide with OSM at 37°C for 4 h did not result in an
increase in the percentage of centrosomes that contained
PKA-RII (Figure 3A), confirming that OSM stimulated the
association of PKA-RII with centrosomes in parental
HepG2 cells by promoting its AKAP-mediated anchoring.
Expression of the AKAP-IS peptide did not prevent the
OSM-stimulated phosphorylation of ERK2 (Figure 3B). To-
gether, the data suggest that expression of the AKAP-IS
peptide reduces the anchoring of PKA-RII to centrosomes,
and, importantly, that it effectively prevents the OSM-stim-
ulated association of PKA-RII with centrosomes.
Interestingly, we noticed that many centrosomes were no
longer positioned near the apical surface in cells expressing
the AKAP-IS peptide (Figure 3C, 2–4, compare with 1–3; cf.
Figure 1, A–D). Indeed, on average no more than 0.5 PKA-
RII-positive and 1.2 -tubulin positive centrosomes per
apical lumen were counted, which is in striking contrast to
the typically 1.0 PKA-RII-positive and 2.3 -tubulin–posi-
tive centrosomes per apical lumen in parental HepG2 cells
or HepG2 cells expressing the scrambled peptide (Figure 3,
D and E). The number of cells participating in an apical
lumen did not change (data not shown). PKA-RII- and
-tubulin–positive centrosomes were localized in proximity
to the nucleus (Figure 3C, 2–4). Inhibition of catalytic PKA
activity with KT5720 or H89 for 4 h did not result in a
relocation of subapical centrosomes in parental HepG2 cells
(Figure 2B), suggesting that the observed loss of subapical
positioning in cells expressing the AKAP-IS peptide oc-
curred independently of altered PKA activity. The perinu-
clear position of the centrosome in AKAP-IS–expressing
cells altered the overall organization of the microtubule
network, as many microtubules were concentrated in the
perinuclear region away from the apical surface (Figure 3C,
4). Microtubules that seemed to be directed toward the
apical domain were also observed (Figure 3C, 5). These data
suggest that expression of the AKAP-IS peptide and con-
comitant reduction of centrosome-associated PKA-RII in-
terferes with the subapical positioning of the centrosome
and the orientation of a major part of the microtubule net-
Figure 2. OSM promotes the association of
PKA-RII with subapically positioned centro-
somes. (A) Polarized HepG2 cells were treated
at 37°C for 4 h with 10 ng/ml OSM or 1 mM
db-cAMP. Cells were then fixed and immuno-
labeled for -tubulin and labeled with TRITC-
phalloidin to determine the number of centro-
somes positioned within a 2-m radius from
the apical surface. (B) OSM stimulates the re-
cruitment of PKA-RII at the centrosomes in
an ERK-, but not PKA-dependent manner.
HepG2 cells were treated with db-cAMP or
OSM at 37°C for 4 h. In other experiments,
cells were treated with OSM in the presence of
the MEK inhibitor PD98059 at 50 M, or with
the PKA inhibitors KT5720 at 10 M or H89 at
10 M. Cells were then fixed and immunola-
beled for PKA-RII and -tubulin to deter-
mine the number of PKA-RII–positive cen-
trosomes. (C) Cells were stimulated with OSM
in the presence of absence of KT-5720, or H89
or db-cAMP, fixed, and (immuno)labeled for
PKA-RII and TRITC-phalloidin to determine
the number of PKA-RII–positive centro-
somes within a 2-m radius from the apical
lumen. (D) PD98059 at 50 M blocks the OSM-
stimulated phosphorylation of ERK1/2, evi-
denced by Western blotting. (E) Western blot
showing the expression level of AKAP350 and
PKA-RII in untreated HepG2 cells and cells
treated with 10 ng/ml OSM or 1 mM db-
cAMP at 37°C for 4 h. (F) Quantification of the
cellular expression of pericentrin in untreated
cells and cells treated with OSM or db-cAMP.
Quantification was based on the measured
fluorescence intensity of immunolabeled cov-
erslips (see Materials and Methods). All data are
expressed as mean  SD of at least three inde-
pendent experiments. Statistical significance
(p  0.05; indicated with asterisks) was deter-
mined using a Student’s t test.
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work in a manner that seems unrelated to the enzymatic
activity of PKA.
Several endosomal compartments such as the CE/SAC and
the rab11a-positive ARE are typically concentrated around the
centrosome in epithelial cells (Casanova et al., 1999; Leung et al.,
2000; Hobdy-Henderson et al., 2003), and they mediate the
transcellular flow of membranes (for review, see Hoekstra et al.,
2004), a process that has been shown to be stimulated by
OSM (van der Wouden et al., 2002). Therefore, we next
examined the subcellular position of the CE/SAC and ARE
in control HepG2 cells and HepG2 cells expressing the AKAP-IS
peptide. The CE/SAC was visualized by the temperature-depen-
dent accumulation of a fluorescent lipid probe, as described pre-
viously (van IJzendoorn and Hoekstra, 1998). In brief, cells were
labeled with NBD-sphingomyelin at 37°C for 30 min,
washed, and incubated at 18°C for another 90 min in buffer
containing 5% (wt/vol) albumin. Cells were then treated
with dithionite at 4°C for 10 min, washed once with buffer,
and examined with epifluorescence microscopy. As shown
in Figure 4, A and B, CE/SAC (open arrows) were oriented
toward the apical surfaces (closed arrow) in HepG2 cells, con-
sistent with previous results (van IJzendoorn and Hoekstra,
1998, 1999, 2000; van IJzendoorn et al., 2004a,b). In contrast, in
HepG2 cells expressing the AKAP-IS peptide, many CE/
SAC (open arrows) were no longer oriented toward the
apical surface (closed arrow), and they displayed a perinu-
clear localization (Figure 4, C and D), in accordance with the
position of the centrosome in these cells (cf. Figure 3C, 2–5).
The ARE was visualized using an antibody raised against
rab11a, a well-established ARE-associated small GTPase
(Casanova et al., 1999; Brown et al., 2000; Leung et al., 2000;
Prekeris et al., 2000). In parental HepG2 cells, rab11a labeling
was exclusively subapical, as expected (Figure 4, F and G).
In HepG2 cells expressing the AKAP-IS peptide, the subapi-
cal rab11a labeling was preserved. In addition to the sub-
apical labeling, however, in these cells rab11a labeling could
also be observed at the perinuclear centrosomes (Figure 4, J
and K, closed arrows). Together, these data show that the
displacement of PKA-RII from centrosomes and the con-
comitant positioning of centrosomes away from the apical
surface spatially separates the CE/SAC from rab11a-posi-
tive ARE, and they suggest that rab11a localizes to a sepa-
ratable subapical and centrosomal pool.
Because (loss of) PKA-RII association with centrosomes
has been correlated to cell cycle progression, we examined
the cell proliferation rate, mitotic index, and cell cycle dis-
Figure 3. In HepG2 cells stably expressing
AKAP-IS peptide centrosomes are positioned
away from apical plasma membranes. (A). Pa-
rental HepG2 cells or HepG2 cells expressing
the AKAP-IS or scrambled (control) peptide
were treated with OSM or buffer (control) at
37°C for 4 h and immunolabeled for -tubulin
and PKA-RII to determine the number of
PKA-RII–positive centrosomes. Note that in
cells expressing the AKAP-IS peptide, the as-
sociation of PKA-RII with centrosomes is de-
creased and OSM is not able to stimulate the
anchoring of PKA RII to centrosomes. Data
are expressed as mean  SD from three inde-
pendent experiments. (B) Western blot show-
ing phosphorylated ERK1/2 and total ERK1/2
in HepG2 cells and HepG2 cells expressing the
AKAP-IS peptide treated for the indicated
time intervals with OSM. (C) HepG2 cells (1
and 3) or HepG2 cells expressing the AKAP-IS
peptide (2, 4, and 5) were immunolabeled for
MRP2 and -tubulin (3–5) or MRP2 and peri-
centrin (1 and 2). Note that in polarized
HepG2 cells stably expressing AKAP-IS pep-
tide, centrosomes (arrows) and the microtu-
bule network are perinuclearly oriented. Im-
age 5 is an enlargement of the boxed region in
image 4. (E) HepG2 cells or HepG2 cells ex-
pressing the AKAP-IS or scrambled peptide
were (immuno)labeled for -tubulin and TRITC-
phalloidin to determine the number of centro-
somes within a 2-m radius from the apical
surface. (F) HepG2 cells or HepG2 cells express-
ing the AKAP-IS or scrambled peptide were
(immuno)labeled for PKA-RII and TRITC-
phalloidin to determine the number of RII-
positive centrosomes within a 2-m radius of
the apical surface. Data are expressed as mean
SD from three independent experiments. Statis-
tical significance was determined using a Stu-
dent’s t test. Bar, 10 m.
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tribution of parental and AKAP-IS–expressing cells. The
proliferation rates, the mitotic index (i.e., percentage of cells
showing typical mitotic DNA figures), and the cell cycle
distribution (measured by fluorescence-activated cell sorting
[FACS]) of parental and AKAP-IS–expressing cells were
comparable (Supplemental Figure S1, B–D), suggesting that
the effects of AKAP-IS expression on centrosome and CE/
SAC positioning are not likely due to changes in cell cycle.
Expression of the PKA-displacing AKAP-IS Peptide
Inhibits OSM- but Not db-cAMP-stimulated Bile
Canalicular Lumen Development
Because the expression of the AKAP-IS peptide prevented
the OSM-stimulated association of PKA-RII with centro-
somes (Figure 3A), we next examined whether expression of
the AKAP-IS peptide also prevented the previously reported
(van der Wouden et al., 2002; van IJzendoorn et al., 2004a)
stimulation of apical bile canalicular lumen development,
i.e., cell polarity, by OSM. For this, AKAP-IS–expressing and
control HepG2 cells (i.e., parental cells or HepG2 cells ex-
pressing the scrambled peptide) were treated with OSM or
buffer (control) at 37°C for 4 h, fixed, and labeled with
TRITC-conjugated phalloidin to identify BC and the nuclear
stain Hoechst. Cells were then examined with epifluores-
cence microscopy, and the ratio bile canalicular lumens
(BC)/100 cells, as a measure for cell polarity (see Materials
and Methods; cf. Zegers and Hoekstra, 1997; van IJzendoorn
and Hoekstra, 2000), was determined. In both AKAP-IS–
expressing and control HepG2 cells the ratio BC/100 cells
was 15 (Figure 5), which, when taken into account that at
least two cells participate in a single BC, means that at least
30% of the cells in the culture were polarized. Treatment of
parental HepG2 cells or HepG2 cells expressing the scrambled
peptide with OSM stimulated the number of apical lumens
with 30% (p  0.05) (Figure 5), consistent with previous
results (van der Wouden et al., 2002; van IJzendoorn et al.,
2004a). Also, db-cAMP stimulated apical lumen development,
evidenced by an increase in their numbers and circumference
(Figure 5). Treatment of HepG2 cells or HepG2 cells expressing
the scrambled peptide with both OSM and db-cAMP aug-
mented the increase in BC numbers (Figure 5). In striking
contrast, treatment of cells expressing the AKAP-IS peptide
with OSM resulted in a 40% decrease in cell polarity (Figure 5),
whereas db-cAMP stimulated apical lumen development in
these cells equally well as in the parental cells (Figure 5).
Treatment with both OSM and db-cAMP resulted in a signif-
icant increase in BC numbers but to a lesser extent in compar-
ison with treatment with db-cAMP alone (Figure 5). These data
indicate that OSM (but not db-cAMP) is unable to stimulate
apical lumen development in AKAP-IS–expressing cells, and,
moreover, causes a loss of preexisting apical surface domains.
Hence, the capacity of OSM to stimulate the anchoring of
PKA-RII to centrosomes is functionally correlated to its con-
trol over apical lumen development.
Expression of the PKA-displacing AKAP-IS Peptide Does
Not Inhibit OSM-stimulated Basolateral to Apical
Transcytosis
The stimulatory effect of OSM on apical lumen development
in HepG2 cells was previously shown to correlate with a
Figure 4. Subcellular distribution of the CE/SAC
and ARE in HepG2 cells expressing the AKAP-IS
peptide. The CE/SAC (A–D, open arrows; fluores-
cently labeled as described in Materials and Methods)
are located close to the apical lumen (marked with
closed arrow) in HepG2 cells (B; corresponding
phase contrast in A, respectively). In cells expressing
the AKAP-IS peptide, the CE/SAC (D, open arrows)
is oriented away from the apical surface (correspond-
ing phase contrast in C). In HepG2 cells, the rab11a-
positive ARE (G) remains close to the apical surface (F
and H). In HepG2 cells expressing the AKAP-IS pep-
tide, rab11a (K) is also located close to the apical sur-
face (J and L), whereas some immunoreactivity is ob-
served at perinuclear structures reminiscent of
centrosomes (K and L, arrows). Nuclei in E and I are
stained with 4,6-diamidino-2-phenylindole. Bar, 10
m.
Figure 5. Displacement of PKA RII form its natural anchoring sites
inhibits OSM-stimulated polarity development. Stimulation of parental
HepG2 cells or HepG2 cells expressing the scrambled control peptide
with either 10 ng/ml OSM, 1 mM db-AMP, or OSM  db-cAMP for
4 h stimulates the development of apical lumens. Expression of
AKAP-IS peptide abrogates OSM-, but not db-cAMP-mediated
stimulation of polarity. Data are expressed as mean SD from three
independent experiments. Statistical significance was determined
using a Student’s t test.
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stimulatory effect of the cytokine on basolateral-to-apical
membrane trafficking, evidenced by an increased transcyto-
sis of the fluorescent lipid analogue NBD-sphingomyelin
(van der Wouden et al., 2002). Therefore, we next examined
whether OSM could stimulate basolateral-to-apical mem-
brane trafficking in cells expressing the AKAP-IS peptide.
For this, cells cultured on glass coverslips were labeled
with NBD-sphingomyelin as described previously (van der
Wouden et al., 2002). In brief, control cells or cells expressing
the AKAP-IS peptide were preincubated with OSM for 30
min, and the basolateral surface was incubated with NBD-
sphingomyelin for 30 min at 4°C in the presence or absence
of OSM. Cells were then washed and the fluorescent lipid
analogue was chased at 37°C for 15 or 30 min in buffer in the
presence or absence of OSM. Finally, cells were washed with
ice-cold HBSS to stop membrane flow and the coverslips
were mounted for immediate microscopy. Bile canalicular
lumens were first identified with phase contrast and scored
as NBD positive or negative with epifluorescence. Figure 6,
A–D, shows that the lipid analogue reached the apical sur-
face domain in untreated or OSM-treated cells expressing
the AKAP-IS peptide, similarly as previously shown in con-
trol HepG2 cells (Zegers and Hoekstra, 1997; van IJzendoorn
and Hoekstra, 1999, 2000; van der Wouden et al., 2002) and
consistent with previous results (Wojtal et al., 2006). Baso-
laterally derived NBD-sphingomyelin reached 74 and 89%
of the bile canalicular lumens after a chase of 15 and 30 min,
respectively, in parental cells. Interestingly, treatment of
both control and AKAP-IS–expressing cells with OSM stim-
ulated basolateral to apical membrane trafficking as evi-
denced by an increase in the percentage of NBD-positive
lumens after a 15- and 30-min chase to 92 and 100%, respec-
tively (Figure 6E). These data show that, whereas OSM
decreases the number of apical lumens in cells expressing
the AKAP-IS peptide (cf. Figure 3), OSM is still capable of
promoting transcytotic membrane trafficking to the remain-
ing apical surfaces, and, therefore, strongly suggest that the
OSM-stimulated loss of apical lumens in AKAP-IS–express-
ing cells cannot be attributed to an inhibition of apical sur-
face-directed membrane trafficking.
DISCUSSION
The present study demonstrates that PKA-RII anchoring
at the centrosome and the coinciding subapical positioning
of the centrosome plays a crucial role in OSM-, but not
cAMP-mediated stimulation of apical bile canalicular lumen
development in hepatic HepG2 cells.
Immunofluorescence microscopic analysis reveals that
48% of the centrosomes in a typical HepG2 cell population
contain detectable amounts of PKA-RII. This increases to
65% (p  0.01) in oncostatin M-treated cells, but not in
db-cAMP-treated cells. The enhanced association of PKA-
RII with centrosomes is a result of anchoring via AKAPs as
expression of the PKA-RII-displacing peptide AKAP-IS
(Alto et al., 2003), which reduced the anchoring of PKA-RII
to centrosomes, prevents the stimulatory effect of OSM. A
scrambled version of the peptide was without effect. The
association and dissociation of PKA-RII from centrosomal
AKAPs has been shown to be regulated by phosphorylation
of PKA-RII in mitotic cells (Carlson et al., 2001). In our
studies, however, changes in the expression level of the
cyclin-dependent kinase inhibitor p27Kip1 (indicative for
altered cell cycle progression) or electrophoretic mobility
shifts (indicative for changes in PKA-RII phosphorylation
status) were not observed in response to OSM. Furthermore,
expression of the AKAP-IS peptide did not significantly alter
the proliferation rate, mitotic index, or cell cycle phase dis-
tribution pattern of the cell culture. As a part of the under-
lying molecular mechanism, our data suggest that signaling
through MEK and ERK2 downstream of OSM stimulation is
involved in stimulating centrosomal anchoring of PKA-RII.
Fluorescence microscopical examination of cells treated with
OSM for 30 min or 4 h and subsequently processed for
phospho-ERK1/2 immunolabeling did not reveal a clear
association of ERK1/2 with centrosomes (our unpublished
data), suggesting that ERK2 does not or only transiently acts
at the centrosome. How MEK–ERK2-dependent anchoring
of PKA-RII to centrosomal AKAPs is regulated at the mo-
lecular level thus requires further studies.
Most PKA-RII–recruiting centrosomes displayed a sub-
apical position. The tethering of PKA-RII to centrosomes
may serve to reinforce the subapical position of these cen-
trosomes. Indeed, the stable expression of the AKAP-IS pep-
tide results in a perinuclear position of most centrosomes. A
scrambled version of the peptide was without effect.
Whereas reduced centrosomal PKA-RII anchoring clearly
affects the subapical position of the centrosome, our data
show that subapical centrosome positioning is unaffected by
two structurally distinct PKA inhibitors (H89 and KT5720),
and, therefore, is likely to be unrelated to enzymatic PKA
activity. Intriguingly, even though the displacement of PKA-
RII from centrosomes is incomplete, the resulting effect on
centrosome position is prominent, which may suggest that
the quantity of anchored PKA-RII, possibly proportionate
to other centrosome-anchored (regulatory) molecules, rather
than the anchoring of PKA-RII as such, controls subapical
centrosome positioning. The molecular mechanisms under-
lying the subapical positioning of (PKA-RII–positive) centro-
somes in hepatocytes requires further studies. Cytoskeletal
elements are likely to be involved in this, possibly involving
intermediate (cytokeratin) filaments that have been reported to
anchor centrosomes to the apical surface of intestinal epithelial
Caco-2 cells (Salas, 1999).
Concomitant with the perinuclear positioning of the cen-
trosome in cells expressing the PKA-displacing peptide, also
the subcellular distribution of the CE/SAC shifted from the
subapical to the perinuclear region. Interestingly, the sub-
Figure 6. Basolateral-to-apical transcytosis of C6-NBD-SM is stim-
ulated in OSM-treated HepG2 cells that express or do not express
the AKAP-IS peptide. HepG2 cells expressing the AKAP-IS peptide
or not were labeled with 4 M C6-NBD-SM for 30 min at 4°C.
Subsequently, the cells were washed and incubated with or without
OSM for another 30 min at 4°C. Transport was triggered in the
presence or absence of OSM by incubating the cells at 37°C. A–D
show that the lipid analogue readily reaches the apical surface of
(OSM-treated) cells expressing the AKAP-IS peptide, very similar to
control HepG2 cells (cf. van der Wouden et al., 2002). After different
time intervals, cells were cooled to block transport, and the number
of NBD-positive BCs was determined (E). Data are expressed as
mean  SD from three independent experiments. Statistical signif-
icance was determined using a Student’s t test.
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apical localization of rab11a-positive ARE is preserved in
cells expressing the AKAP-IS peptide, although an addi-
tional pool of rab11a was associated with the perinuclear
centrosomes. These data indicate that common endosomes
and apical recycling endosomes can be spatially separated,
underscoring that these represent distinct entities (Brown et
al., 2000; Leung et al., 2000; Wang et al., 2000). Whereas
basolateral-to-apical membrane trafficking, i.e., transcytosis,
in epithelial cells including hepatocytes involves sequential
passage through an early endosome, common endosome,
and apical recycling endosome (for review, see Tuma and
Hubbard, 2003), the spatial separation of the latter two as
observed in cells expressing the AKAP-IS peptide does not
seem to impede constitutive or oncostatin M-stimulated
transcytosis. Because the stimulatory effect of OSM on apical
lumen development has been shown to require apical sur-
face-directed membrane flow from common endosomes
(van IJzendoorn et al., 2004a,b), the combined data suggest
that apical surface-directed membrane trafficking is neces-
sary but not sufficient for OSM-stimulated apical lumen
development.
Importantly, the ERK2-mediated anchoring of PKA-RII
at the centrosome and the concomitant subapical position of
PKA-RII–positive centrosomes seems essential for OSM to
stimulate apical bile canalicular lumen development, a pro-
cess that was previously shown to require the enzymatic
activity of PKA (van der Wouden et al., 2002). In fact, in
AKAP-IS–expressing cells that show reduced centrosomal
anchoring of PKA-RII and that are inhibited in their capa-
bility to position the centrosome subapically, oncostatin M
decreases cell polarity, evidenced by a loss of apical lumens.
Although the underlying mechanism for the decrease in cell
polarity remains unknown, the data suggest that the ability
of oncostatin M to stimulate the association of PKA-RII
with centrosomes and the subcellular positioning of PKA-
RII–positive centrosomes is vital for the outcome of the
oncostatin M-elicited cellular response. We thus propose
that OSM-stimulated anchoring of PKA-RII to centrosomes
may serve to reinforce or stabilize the subapical position of
the centrosome and that this is necessary for properly relay-
ing the signals elicited by specific extracellular ligands such
as OSM to subapically located effector molecules that par-
ticipate in the development of bile canalicular lumens in
manner that is uncoupled from lumen-directed trafficking.
Strikingly, the inhibition of centrosomal PKA-RII anchor-
ing and apical centrosome positioning in cells expressing the
AKAP-IS peptide does not affect apical lumen development
in unstimulated or in db-cAMP-stimulated cells. This im-
plies that the regulated centrosomal anchoring of PKA-RII
and subapical centrosome positioning is not essential for
apical lumen development per se, but rather for apical lu-
men development in response to specific signaling mole-
cules such as OSM. These data underscore that, in a single
hepatic cell line (HepG2), multiple PKA-dependent signal-
ing pathways operate in parallel in the process of polarity
development and that centrosome-anchored PKA-RII and
subapical centrosome positioning are important in some of
these pathways.
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